SCHEMBL9119166

SCHEMBL9119166

CC1=C(C(=O)OC(C)C)C(c2ccc(C(F)(F)F)cc2)C(C(=O)OC(C)C)=C(C)N1C

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.51
HSD17B10 Q99714 2/20 0.51
NPSR1 Q6W5P4 4/20 0.50
KDM4E B2RXH2 3/20 0.50
HPGD P15428 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
HSP90AA1 P07900 1/20 0.47
HSP90AB1 P08238 1/20 0.47
GAA P10253 2/20 0.47
HTT P42858 1/20 0.46
LMNA P02545 3/20 0.45
ALDH1A1 P00352 2/20 0.45
ALOX12 P18054 1/20 0.45
PYGM P11217 3/20 0.44
ADORA2B P29275 3/20 0.44
PYGL P06737 2/20 0.44
MAPK1 P28482 2/20 0.43
POLB P06746 1/20 0.43
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9122440 0.95 TSHR (0.60) TSHRHSD17B10NPSR1KDM4EHPGD
SCHEMBL9119964 0.89 HTT (0.48) TSHRHSD17B10NPSR1KDM4EHPGD
SCHEMBL16187000 0.87 HSP90AA1 (0.43) TSHRHSD17B10NPSR1KDM4EHPGD
SCHEMBL9121117 0.87 TSHR (0.56) TSHRHSD17B10NPSR1KDM4EHPGD
SCHEMBL7934386 0.86 TSHR (0.69) TSHRHSD17B10NPSR1KDM4EHPGD
SCHEMBL9120147 0.84 NPSR1 (0.69) TSHRHSD17B10NPSR1KDM4EHPGD
SCHEMBL9363806 0.82 HSP90AA1 (0.39) TSHRHSD17B10NPSR1KDM4EHPGD
SCHEMBL14986934 0.82 TSHR (0.63) TSHRHSD17B10NPSR1KDM4EHPGD
SCHEMBL9117834 0.81 TSHR (0.47) TSHRHSD17B10NPSR1KDM4EHPGD
SCHEMBL21116053 0.80 HTT (0.71) TSHRHSD17B10NPSR1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0451654-B1 Use of N-alkylated 1,4-dihydropyridine carboxylic acid esters as drugs, new compounds and process for their preparation BAYER AG (DE) 1994-09-07 EP claimed
US-5234935-A Preventing myocardial infarct BAYER AKTIENGESELLSCHAFT (DE) 1993-08-10 US claimed
US-5432185-A Treating patients exhibiting acute or chronic ischaemic disorders associated with disorders of microcirculation, without lowering or increasing blood pressure BAYER AKTIENGESELLSCHAFT (DE) 1995-07-11 US disclosed
US-5234935-A Preventing myocardial infarct BAYER AKTIENGESELLSCHAFT (DE) 1993-08-10 US disclosed